Drug-induced kidney disease: a study of the Japan Renal Biopsy Registry from 2007 to 2015 View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-11-21

AUTHORS

Hitoshi Yokoyama, Ichie Narita, Hitoshi Sugiyama, Michio Nagata, Hiroshi Sato, Yoshihiko Ueda, Seiichi Matsuo

ABSTRACT

IntroductionThe Japan Renal Biopsy Registry (J-RBR) was started in 2007 by the Committee for the Standardization of Renal Pathological Diagnosis and the Committee for the Kidney Disease Registry of the Japanese Society of Nephrology. The purpose of this report is to clarify drug-induced kidney disease (DIKD) of renal biopsied cases in Japan.Subjects and methodsWe analyzed the data of 26,535 cases that were registered in the J-RBR from 2007 to 2015.ResultsBased on clinical and pathological diagnoses, 328 cases (176 males and 152 females) of renal biopsy-proven DIKD were registered in the J-RBR from 2007 to 2015 (1.24 % of all cases). The frequency of DIKD increased with age. The number of cases peaked in the 6th–8th decade in all pathological categories, except for the number of chronic tubulointerstitial lesions (CTIL), which peaked in the 4th–5th decade. Overall, the frequency of DIKD was 3 times higher in the 7th decade than in the 2nd decade (1.86 vs. 0.62 %). The main clinical diagnoses were DIKD in 150 cases (45.7 %), nephrotic syndrome in 66 cases (20.1 %), chronic nephritic syndrome in 55 cases (16.8 %), and rapidly progressive glomerulonephritis in 30 cases (9.1 %). DIKD was registered as a secondary diagnosis in 136 cases (41.5 %). The pathological findings of these cases were glomerular lesions in 105 cases (32.0 %), acute tubulointerstitial lesions (ATIL) in 87 cases (26.5 %), CTIL in 72 cases (22.0 %), and sclerotic glomerular lesions and/or nephrosclerosis in 18 cases (5.5 %). ATIL and CTIL were mainly found in cases in which DIKD was diagnosed on the basis of the patient’s clinical findings. In addition, nephrotic syndrome-related membranous nephropathy (MN) was the major cause of renal damage in 59.4 % of the cases involving glomerular injuries. According to the CGA risk classification, high-risk (red zone) cases accounted for 56.1 % of all cases of DIKD and 75.9, 64.9, and 33.3 % of the cases involving ATIL, CTIL, and glomerular injuries, respectively. The causative drugs were identified in 102 cases, including bucillamine in 38 cases of MN, gemcitabine in 3 cases of thrombotic microangiopathy, and other anticancer drugs in 14 cases (anti-vascular endothelial growth factor drugs in 3 cases and propyl thiouracil in 3 cases of anti-neutrophil cytoplasmic antibody-related nephritis).ConclusionOur analysis of the J-RBR revealed that DIKD mainly affects elderly people in Japan. ATIL or CTIL were found in approximately half of the biopsied cases of DIKD, and one-third involved glomerular lesions, mainly MN or clinical nephrotic syndrome. More... »

PAGES

720-730

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10157-015-1201-4

DOI

http://dx.doi.org/10.1007/s10157-015-1201-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1012426562

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26590949


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Distribution", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biopsy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Japan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Predictive Value of Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Registries", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sex Distribution", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Nephrology, Kanazawa Medical University School of Medicine, 1-1 Daigaku, 920-0293, Uchinada, Ishikawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411998.c", 
          "name": [
            "Department of Nephrology, Kanazawa Medical University School of Medicine, 1-1 Daigaku, 920-0293, Uchinada, Ishikawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yokoyama", 
        "givenName": "Hitoshi", 
        "id": "sg:person.011755063652.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011755063652.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan", 
          "id": "http://www.grid.ac/institutes/grid.260975.f", 
          "name": [
            "Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Narita", 
        "givenName": "Ichie", 
        "id": "sg:person.012103575621.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012103575621.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.261356.5", 
          "name": [
            "Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sugiyama", 
        "givenName": "Hitoshi", 
        "id": "sg:person.0767063345.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767063345.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Faculty of Medicine, University of Tsukuba, Ibaragi, Japan", 
          "id": "http://www.grid.ac/institutes/grid.20515.33", 
          "name": [
            "Department of Pathology, Faculty of Medicine, University of Tsukuba, Ibaragi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nagata", 
        "givenName": "Michio", 
        "id": "sg:person.01022702772.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022702772.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan", 
          "id": "http://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sato", 
        "givenName": "Hiroshi", 
        "id": "sg:person.01072667343.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072667343.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Dokkyo Medical University Koshigaya Hospital, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.470088.3", 
          "name": [
            "Department of Pathology, Dokkyo Medical University Koshigaya Hospital, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ueda", 
        "givenName": "Yoshihiko", 
        "id": "sg:person.015255050342.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015255050342.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan", 
          "id": "http://www.grid.ac/institutes/grid.27476.30", 
          "name": [
            "Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsuo", 
        "givenName": "Seiichi", 
        "id": "sg:person.01024375011.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024375011.44"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10157-011-0430-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017916284", 
          "https://doi.org/10.1007/s10157-011-0430-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10157-012-0593-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035076317", 
          "https://doi.org/10.1007/s10157-012-0593-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10157-014-0993-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030532510", 
          "https://doi.org/10.1007/s10157-014-0993-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10157-012-0673-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033628050", 
          "https://doi.org/10.1007/s10157-012-0673-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10157-014-1022-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015007506", 
          "https://doi.org/10.1007/s10157-014-1022-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.2011.58", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048980159", 
          "https://doi.org/10.1038/clpt.2011.58"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10157-012-0746-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043867412", 
          "https://doi.org/10.1007/s10157-012-0746-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10157-013-0778-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017987826", 
          "https://doi.org/10.1007/s10157-013-0778-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-11-21", 
    "datePublishedReg": "2015-11-21", 
    "description": "IntroductionThe Japan Renal Biopsy Registry (J-RBR) was started in 2007 by the Committee for the Standardization of Renal Pathological Diagnosis and the Committee for the Kidney Disease Registry of the Japanese Society of Nephrology. The purpose of this report is to clarify drug-induced kidney disease (DIKD) of renal biopsied cases in Japan.Subjects and methodsWe analyzed the data of 26,535 cases that were registered in the J-RBR from 2007 to 2015.ResultsBased on clinical and pathological diagnoses, 328 cases (176 males and 152 females) of renal biopsy-proven DIKD were registered in the J-RBR from 2007 to 2015 (1.24\u00a0% of all cases). The frequency of DIKD increased with age. The number of cases peaked in the 6th\u20138th decade in all pathological categories, except for the number of chronic tubulointerstitial lesions (CTIL), which peaked in the 4th\u20135th decade. Overall, the frequency of DIKD was 3 times higher in the 7th decade than in the 2nd decade (1.86 vs. 0.62\u00a0%). The main clinical diagnoses were DIKD in 150 cases (45.7\u00a0%), nephrotic syndrome in 66 cases (20.1\u00a0%), chronic nephritic syndrome in 55 cases (16.8\u00a0%), and rapidly progressive glomerulonephritis in 30 cases (9.1\u00a0%). DIKD was registered as a secondary diagnosis in 136 cases (41.5\u00a0%). The pathological findings of these cases were glomerular lesions in 105 cases (32.0\u00a0%), acute tubulointerstitial lesions (ATIL) in 87 cases (26.5\u00a0%), CTIL in 72 cases (22.0\u00a0%), and sclerotic glomerular lesions and/or nephrosclerosis in 18 cases (5.5\u00a0%). ATIL and CTIL were mainly found in cases in which DIKD was diagnosed on the basis of the patient\u2019s clinical findings. In addition, nephrotic syndrome-related membranous nephropathy (MN) was the major cause of renal damage in 59.4\u00a0% of the cases involving glomerular injuries. According to the CGA risk classification, high-risk (red zone) cases accounted for 56.1\u00a0% of all cases of DIKD and 75.9, 64.9, and 33.3\u00a0% of the cases involving ATIL, CTIL, and glomerular injuries, respectively. The causative drugs were identified in 102 cases, including bucillamine in 38 cases of MN, gemcitabine in 3 cases of thrombotic microangiopathy, and other anticancer drugs in 14 cases (anti-vascular endothelial growth factor drugs in 3 cases and propyl thiouracil in 3 cases of anti-neutrophil cytoplasmic antibody-related nephritis).ConclusionOur analysis of the J-RBR revealed that DIKD mainly affects elderly people in Japan. ATIL or CTIL were found in approximately half of the biopsied cases of DIKD, and one-third involved glomerular lesions, mainly MN or clinical nephrotic syndrome.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10157-015-1201-4", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1117096", 
        "issn": [
          "1342-1751", 
          "1437-7799"
        ], 
        "name": "Clinical and Experimental Nephrology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "20"
      }
    ], 
    "keywords": [
      "drug-induced kidney disease", 
      "chronic tubulointerstitial lesions", 
      "acute tubulointerstitial lesions", 
      "Japan Renal Biopsy Registry", 
      "Renal Biopsy Registry", 
      "membranous nephropathy", 
      "J-RBR", 
      "glomerular lesions", 
      "tubulointerstitial lesions", 
      "Biopsy Registry", 
      "nephrotic syndrome", 
      "clinical findings", 
      "glomerular injury", 
      "pathological diagnosis", 
      "cases of MN", 
      "main clinical diagnoses", 
      "chronic nephritic syndrome", 
      "sclerotic glomerular lesions", 
      "high-risk cases", 
      "patient's clinical findings", 
      "clinical nephrotic syndrome", 
      "renal pathological diagnosis", 
      "progressive glomerulonephritis", 
      "causative drugs", 
      "thrombotic microangiopathy", 
      "renal damage", 
      "nephritic syndrome", 
      "pathological findings", 
      "kidney disease", 
      "secondary diagnosis", 
      "Disease Registry", 
      "number of cases", 
      "ConclusionOur analysis", 
      "clinical diagnosis", 
      "lesions", 
      "pathological categories", 
      "major cause", 
      "registry", 
      "syndrome", 
      "diagnosis", 
      "risk classification", 
      "elderly people", 
      "injury", 
      "anticancer drugs", 
      "drugs", 
      "Japanese Society", 
      "nephrosclerosis", 
      "microangiopathy", 
      "glomerulonephritis", 
      "nephropathy", 
      "bucillamine", 
      "gemcitabine", 
      "cases", 
      "nephrology", 
      "MethodsWe", 
      "findings", 
      "disease", 
      "age", 
      "Committee", 
      "cause", 
      "subjects", 
      "report", 
      "damage", 
      "frequency", 
      "decades", 
      "half", 
      "study", 
      "number", 
      "Japan", 
      "people", 
      "standardization", 
      "purpose", 
      "categories", 
      "data", 
      "addition", 
      "classification", 
      "time", 
      "analysis", 
      "basis", 
      "society"
    ], 
    "name": "Drug-induced kidney disease: a study of the Japan Renal Biopsy Registry from 2007 to 2015", 
    "pagination": "720-730", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1012426562"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10157-015-1201-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26590949"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10157-015-1201-4", 
      "https://app.dimensions.ai/details/publication/pub.1012426562"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:33", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_665.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10157-015-1201-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10157-015-1201-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10157-015-1201-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10157-015-1201-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10157-015-1201-4'


 

This table displays all metadata directly associated to this object as RDF triples.

313 TRIPLES      21 PREDICATES      133 URIs      117 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10157-015-1201-4 schema:about N078ae47dd3de4460be0e59d6b4f07814
2 N2463afd4c06944cfa47f254d88ffe0c0
3 N5d723b3f7119427f9a2742172b60ed06
4 N76de8c8ba1684012ad95f2ba5d90f2e1
5 N98dad9346b284280a4e945abc36f6745
6 N9d31319210b04ae59fff1c9e7e9cf52f
7 Naaf7ef2367454f39b8ada6ae644e22c0
8 Nb4ca526bf3864be2b947195b3a642ff8
9 Nb758bbc777084de68fc4418fa819458d
10 Nbcad0ac53e05450b98126b51eaa79be8
11 Nc6e42156a97e46f79106636d81168004
12 Nc776faeefd3044de83b8e265b570ee81
13 Nd175f8b8da4d4858aab93f6f1205a70f
14 Nda2be258adb342029acae7471570aaa2
15 Ndabc1b0217ee4e99bd58f72687fddafe
16 Ndd0c255161914a8485d17364e7250709
17 Ne0e7edac5ea34381b81ce4ce7f07aad2
18 Ne20669da5937483ca834181bc1866ce7
19 Nf726722d922d434a940592aa2c5a5d56
20 Nfba9a78729864aefa750c2ec288edbf2
21 anzsrc-for:11
22 anzsrc-for:1103
23 schema:author N26f67bc31f4a4f7a932d7bd74464891d
24 schema:citation sg:pub.10.1007/s10157-011-0430-4
25 sg:pub.10.1007/s10157-012-0593-7
26 sg:pub.10.1007/s10157-012-0673-8
27 sg:pub.10.1007/s10157-012-0746-8
28 sg:pub.10.1007/s10157-013-0778-8
29 sg:pub.10.1007/s10157-014-0993-y
30 sg:pub.10.1007/s10157-014-1022-x
31 sg:pub.10.1038/clpt.2011.58
32 schema:datePublished 2015-11-21
33 schema:datePublishedReg 2015-11-21
34 schema:description IntroductionThe Japan Renal Biopsy Registry (J-RBR) was started in 2007 by the Committee for the Standardization of Renal Pathological Diagnosis and the Committee for the Kidney Disease Registry of the Japanese Society of Nephrology. The purpose of this report is to clarify drug-induced kidney disease (DIKD) of renal biopsied cases in Japan.Subjects and methodsWe analyzed the data of 26,535 cases that were registered in the J-RBR from 2007 to 2015.ResultsBased on clinical and pathological diagnoses, 328 cases (176 males and 152 females) of renal biopsy-proven DIKD were registered in the J-RBR from 2007 to 2015 (1.24 % of all cases). The frequency of DIKD increased with age. The number of cases peaked in the 6th–8th decade in all pathological categories, except for the number of chronic tubulointerstitial lesions (CTIL), which peaked in the 4th–5th decade. Overall, the frequency of DIKD was 3 times higher in the 7th decade than in the 2nd decade (1.86 vs. 0.62 %). The main clinical diagnoses were DIKD in 150 cases (45.7 %), nephrotic syndrome in 66 cases (20.1 %), chronic nephritic syndrome in 55 cases (16.8 %), and rapidly progressive glomerulonephritis in 30 cases (9.1 %). DIKD was registered as a secondary diagnosis in 136 cases (41.5 %). The pathological findings of these cases were glomerular lesions in 105 cases (32.0 %), acute tubulointerstitial lesions (ATIL) in 87 cases (26.5 %), CTIL in 72 cases (22.0 %), and sclerotic glomerular lesions and/or nephrosclerosis in 18 cases (5.5 %). ATIL and CTIL were mainly found in cases in which DIKD was diagnosed on the basis of the patient’s clinical findings. In addition, nephrotic syndrome-related membranous nephropathy (MN) was the major cause of renal damage in 59.4 % of the cases involving glomerular injuries. According to the CGA risk classification, high-risk (red zone) cases accounted for 56.1 % of all cases of DIKD and 75.9, 64.9, and 33.3 % of the cases involving ATIL, CTIL, and glomerular injuries, respectively. The causative drugs were identified in 102 cases, including bucillamine in 38 cases of MN, gemcitabine in 3 cases of thrombotic microangiopathy, and other anticancer drugs in 14 cases (anti-vascular endothelial growth factor drugs in 3 cases and propyl thiouracil in 3 cases of anti-neutrophil cytoplasmic antibody-related nephritis).ConclusionOur analysis of the J-RBR revealed that DIKD mainly affects elderly people in Japan. ATIL or CTIL were found in approximately half of the biopsied cases of DIKD, and one-third involved glomerular lesions, mainly MN or clinical nephrotic syndrome.
35 schema:genre article
36 schema:isAccessibleForFree true
37 schema:isPartOf N6acfec5407774bf585c6c495b84a9050
38 N6da0f02b4dcc414fb5020baa9cc78ddb
39 sg:journal.1117096
40 schema:keywords Biopsy Registry
41 Committee
42 ConclusionOur analysis
43 Disease Registry
44 J-RBR
45 Japan
46 Japan Renal Biopsy Registry
47 Japanese Society
48 MethodsWe
49 Renal Biopsy Registry
50 acute tubulointerstitial lesions
51 addition
52 age
53 analysis
54 anticancer drugs
55 basis
56 bucillamine
57 cases
58 cases of MN
59 categories
60 causative drugs
61 cause
62 chronic nephritic syndrome
63 chronic tubulointerstitial lesions
64 classification
65 clinical diagnosis
66 clinical findings
67 clinical nephrotic syndrome
68 damage
69 data
70 decades
71 diagnosis
72 disease
73 drug-induced kidney disease
74 drugs
75 elderly people
76 findings
77 frequency
78 gemcitabine
79 glomerular injury
80 glomerular lesions
81 glomerulonephritis
82 half
83 high-risk cases
84 injury
85 kidney disease
86 lesions
87 main clinical diagnoses
88 major cause
89 membranous nephropathy
90 microangiopathy
91 nephritic syndrome
92 nephrology
93 nephropathy
94 nephrosclerosis
95 nephrotic syndrome
96 number
97 number of cases
98 pathological categories
99 pathological diagnosis
100 pathological findings
101 patient's clinical findings
102 people
103 progressive glomerulonephritis
104 purpose
105 registry
106 renal damage
107 renal pathological diagnosis
108 report
109 risk classification
110 sclerotic glomerular lesions
111 secondary diagnosis
112 society
113 standardization
114 study
115 subjects
116 syndrome
117 thrombotic microangiopathy
118 time
119 tubulointerstitial lesions
120 schema:name Drug-induced kidney disease: a study of the Japan Renal Biopsy Registry from 2007 to 2015
121 schema:pagination 720-730
122 schema:productId N1016440678f94e7392222ee102eb19ef
123 N6abd25b151a64f9599889f26365787f9
124 Ne25456ab838642e49d51ad69b650a8ce
125 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012426562
126 https://doi.org/10.1007/s10157-015-1201-4
127 schema:sdDatePublished 2022-12-01T06:33
128 schema:sdLicense https://scigraph.springernature.com/explorer/license/
129 schema:sdPublisher Nc4e8a354624744319c609a109bb5eea5
130 schema:url https://doi.org/10.1007/s10157-015-1201-4
131 sgo:license sg:explorer/license/
132 sgo:sdDataset articles
133 rdf:type schema:ScholarlyArticle
134 N078ae47dd3de4460be0e59d6b4f07814 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Aged
136 rdf:type schema:DefinedTerm
137 N1016440678f94e7392222ee102eb19ef schema:name doi
138 schema:value 10.1007/s10157-015-1201-4
139 rdf:type schema:PropertyValue
140 N15fd7c9feb51421bab6380c09766e272 rdf:first sg:person.01072667343.29
141 rdf:rest N92c3eca0e9774457bd7e6044c0dd4bc4
142 N2463afd4c06944cfa47f254d88ffe0c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Risk Factors
144 rdf:type schema:DefinedTerm
145 N26f67bc31f4a4f7a932d7bd74464891d rdf:first sg:person.011755063652.87
146 rdf:rest N4e7543a51c814dacbca6d4a847ff1046
147 N3b2403d55a2d46c8b94833ac445ed8dc rdf:first sg:person.0767063345.54
148 rdf:rest Nf3e2f125579e4ee29314b2e096ad3657
149 N4e7543a51c814dacbca6d4a847ff1046 rdf:first sg:person.012103575621.85
150 rdf:rest N3b2403d55a2d46c8b94833ac445ed8dc
151 N5d723b3f7119427f9a2742172b60ed06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Middle Aged
153 rdf:type schema:DefinedTerm
154 N6abd25b151a64f9599889f26365787f9 schema:name dimensions_id
155 schema:value pub.1012426562
156 rdf:type schema:PropertyValue
157 N6acfec5407774bf585c6c495b84a9050 schema:volumeNumber 20
158 rdf:type schema:PublicationVolume
159 N6da0f02b4dcc414fb5020baa9cc78ddb schema:issueNumber 5
160 rdf:type schema:PublicationIssue
161 N76de8c8ba1684012ad95f2ba5d90f2e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Male
163 rdf:type schema:DefinedTerm
164 N92c3eca0e9774457bd7e6044c0dd4bc4 rdf:first sg:person.015255050342.77
165 rdf:rest Na58101c68d08483db2191be4490c4b8b
166 N98dad9346b284280a4e945abc36f6745 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Humans
168 rdf:type schema:DefinedTerm
169 N9d31319210b04ae59fff1c9e7e9cf52f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Adult
171 rdf:type schema:DefinedTerm
172 Na58101c68d08483db2191be4490c4b8b rdf:first sg:person.01024375011.44
173 rdf:rest rdf:nil
174 Naaf7ef2367454f39b8ada6ae644e22c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Kidney
176 rdf:type schema:DefinedTerm
177 Nb4ca526bf3864be2b947195b3a642ff8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Adolescent
179 rdf:type schema:DefinedTerm
180 Nb758bbc777084de68fc4418fa819458d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Aged, 80 and over
182 rdf:type schema:DefinedTerm
183 Nbcad0ac53e05450b98126b51eaa79be8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Young Adult
185 rdf:type schema:DefinedTerm
186 Nc4e8a354624744319c609a109bb5eea5 schema:name Springer Nature - SN SciGraph project
187 rdf:type schema:Organization
188 Nc6e42156a97e46f79106636d81168004 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Predictive Value of Tests
190 rdf:type schema:DefinedTerm
191 Nc776faeefd3044de83b8e265b570ee81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Biopsy
193 rdf:type schema:DefinedTerm
194 Nd175f8b8da4d4858aab93f6f1205a70f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Japan
196 rdf:type schema:DefinedTerm
197 Nda2be258adb342029acae7471570aaa2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Female
199 rdf:type schema:DefinedTerm
200 Ndabc1b0217ee4e99bd58f72687fddafe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Sex Distribution
202 rdf:type schema:DefinedTerm
203 Ndd0c255161914a8485d17364e7250709 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Time Factors
205 rdf:type schema:DefinedTerm
206 Ne0e7edac5ea34381b81ce4ce7f07aad2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
207 schema:name Kidney Diseases
208 rdf:type schema:DefinedTerm
209 Ne20669da5937483ca834181bc1866ce7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
210 schema:name Age Distribution
211 rdf:type schema:DefinedTerm
212 Ne25456ab838642e49d51ad69b650a8ce schema:name pubmed_id
213 schema:value 26590949
214 rdf:type schema:PropertyValue
215 Nf3e2f125579e4ee29314b2e096ad3657 rdf:first sg:person.01022702772.51
216 rdf:rest N15fd7c9feb51421bab6380c09766e272
217 Nf726722d922d434a940592aa2c5a5d56 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
218 schema:name Child
219 rdf:type schema:DefinedTerm
220 Nfba9a78729864aefa750c2ec288edbf2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
221 schema:name Registries
222 rdf:type schema:DefinedTerm
223 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
224 schema:name Medical and Health Sciences
225 rdf:type schema:DefinedTerm
226 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
227 schema:name Clinical Sciences
228 rdf:type schema:DefinedTerm
229 sg:journal.1117096 schema:issn 1342-1751
230 1437-7799
231 schema:name Clinical and Experimental Nephrology
232 schema:publisher Springer Nature
233 rdf:type schema:Periodical
234 sg:person.01022702772.51 schema:affiliation grid-institutes:grid.20515.33
235 schema:familyName Nagata
236 schema:givenName Michio
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022702772.51
238 rdf:type schema:Person
239 sg:person.01024375011.44 schema:affiliation grid-institutes:grid.27476.30
240 schema:familyName Matsuo
241 schema:givenName Seiichi
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024375011.44
243 rdf:type schema:Person
244 sg:person.01072667343.29 schema:affiliation grid-institutes:grid.69566.3a
245 schema:familyName Sato
246 schema:givenName Hiroshi
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072667343.29
248 rdf:type schema:Person
249 sg:person.011755063652.87 schema:affiliation grid-institutes:grid.411998.c
250 schema:familyName Yokoyama
251 schema:givenName Hitoshi
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011755063652.87
253 rdf:type schema:Person
254 sg:person.012103575621.85 schema:affiliation grid-institutes:grid.260975.f
255 schema:familyName Narita
256 schema:givenName Ichie
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012103575621.85
258 rdf:type schema:Person
259 sg:person.015255050342.77 schema:affiliation grid-institutes:grid.470088.3
260 schema:familyName Ueda
261 schema:givenName Yoshihiko
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015255050342.77
263 rdf:type schema:Person
264 sg:person.0767063345.54 schema:affiliation grid-institutes:grid.261356.5
265 schema:familyName Sugiyama
266 schema:givenName Hitoshi
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767063345.54
268 rdf:type schema:Person
269 sg:pub.10.1007/s10157-011-0430-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017916284
270 https://doi.org/10.1007/s10157-011-0430-4
271 rdf:type schema:CreativeWork
272 sg:pub.10.1007/s10157-012-0593-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035076317
273 https://doi.org/10.1007/s10157-012-0593-7
274 rdf:type schema:CreativeWork
275 sg:pub.10.1007/s10157-012-0673-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033628050
276 https://doi.org/10.1007/s10157-012-0673-8
277 rdf:type schema:CreativeWork
278 sg:pub.10.1007/s10157-012-0746-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043867412
279 https://doi.org/10.1007/s10157-012-0746-8
280 rdf:type schema:CreativeWork
281 sg:pub.10.1007/s10157-013-0778-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017987826
282 https://doi.org/10.1007/s10157-013-0778-8
283 rdf:type schema:CreativeWork
284 sg:pub.10.1007/s10157-014-0993-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1030532510
285 https://doi.org/10.1007/s10157-014-0993-y
286 rdf:type schema:CreativeWork
287 sg:pub.10.1007/s10157-014-1022-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1015007506
288 https://doi.org/10.1007/s10157-014-1022-x
289 rdf:type schema:CreativeWork
290 sg:pub.10.1038/clpt.2011.58 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048980159
291 https://doi.org/10.1038/clpt.2011.58
292 rdf:type schema:CreativeWork
293 grid-institutes:grid.20515.33 schema:alternateName Department of Pathology, Faculty of Medicine, University of Tsukuba, Ibaragi, Japan
294 schema:name Department of Pathology, Faculty of Medicine, University of Tsukuba, Ibaragi, Japan
295 rdf:type schema:Organization
296 grid-institutes:grid.260975.f schema:alternateName Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
297 schema:name Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
298 rdf:type schema:Organization
299 grid-institutes:grid.261356.5 schema:alternateName Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
300 schema:name Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
301 rdf:type schema:Organization
302 grid-institutes:grid.27476.30 schema:alternateName Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan
303 schema:name Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan
304 rdf:type schema:Organization
305 grid-institutes:grid.411998.c schema:alternateName Department of Nephrology, Kanazawa Medical University School of Medicine, 1-1 Daigaku, 920-0293, Uchinada, Ishikawa, Japan
306 schema:name Department of Nephrology, Kanazawa Medical University School of Medicine, 1-1 Daigaku, 920-0293, Uchinada, Ishikawa, Japan
307 rdf:type schema:Organization
308 grid-institutes:grid.470088.3 schema:alternateName Department of Pathology, Dokkyo Medical University Koshigaya Hospital, Saitama, Japan
309 schema:name Department of Pathology, Dokkyo Medical University Koshigaya Hospital, Saitama, Japan
310 rdf:type schema:Organization
311 grid-institutes:grid.69566.3a schema:alternateName Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan
312 schema:name Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan
313 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...